Prior to the adoption and submission of the Agency’s opinion in accordance with Article 13(7) of Implementing Regulation (EU) No 354/2013, the applicant was given the opportunity to be involved in the process of the preparation of the Agency’s opinion. Between 26 September and 27 November 2024, the applicant was informed about the status of the procedure, provided several written comments during that period in the Register for Biocidal Products and attended the 53rd meeting of the Biocidal Products Committee of the Agency (‘the BPC’) of 27 November 2024. The applicant acknowledged that the tested product contained a higher concentration of sodium hypochlorite but argued that that higher concentration was justified based on the fact that sodium hypochlorite degrades quickly. The tested product contained more sodium hypochlorite than the 5,25 % w/w sodium hypochlorite content set for ‘meta SPC 1 HYPO-CHLOR 5,25 %’ to try to address the issue of the quick degradation of the active substance. Contrary to the views of the applicant, the BPC considered that for products containing unstable active substances, storage stability tests should be conducted on fresh products to ensure their representativeness.
Recital 5, Decision_act (EU) 2025/2214
In forcesince 31 Oct 2025